Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1423786

Cover Image

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1423786

Molecular Diagnostics Reagent Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region:

PUBLISHED:
PAGES: 258 Pages
DELIVERY TIME: 2-5 business days
SELECT AN OPTION
PPT Slides/PDF & Excel (Enterprise License)
USD 4995

Add to Cart

The global Molecular Diagnostics Reagent Market continues its upward trajectory, exhibiting a robust Compound Annual Growth Rate (CAGR) between 2024 and 2031. Forecasts indicate even more promising growth ahead, with an expected CAGR of 8% between 2024 and 2031.

Key Drivers of Growth:

  • Increase in Disease Prevalence: With a surge in diseases such as cancer, HIV, and others, the demand for Molecular Diagnostics Reagents has soared. These reagents play a crucial role in monitoring the efficacy of therapeutic drugs, thereby driving significant growth in the market.
  • Technological Advancements: Continuous advancements in molecular biology have revolutionized disease detection and treatment. Modern molecular diagnostics reagent technologies offer rapid and precise identification of pathogens and genetic mutations, reshaping healthcare paradigms globally. This technological evolution propels the demand for molecular diagnostics reagents, as biologists harness vast amounts of genetic data for enhanced diagnostics and treatment strategies.
  • Increase in Biomarker Development: Heightened investment in biomarker research and development amplifies the market's growth prospects. Biomarkers are increasingly utilized for disease diagnosis, prognosis, and evaluation, spurring the demand for Molecular Diagnostic Reagents. The availability of molecular diagnostic kits for infectious diseases further boosts market expansion, with major corporations actively pursuing biomarker solutions to bolster their portfolios.

Market Challenges:

Despite the optimistic growth outlook, the Molecular Diagnostics Reagent Market faces challenges, notably the "High Cost of Equipment." The substantial expense associated with molecular diagnostics devices, coupled with maintenance, licensing, and operational costs, poses a barrier to market expansion. Small medical institutions and labs with limited capital budgets may struggle to afford sophisticated analyzers, hindering widespread adoption of molecular diagnostics technologies.

Impact of COVID-19:

The COVID-19 pandemic, while detrimental to the global economy, has catalyzed growth in the Molecular Diagnostics Reagent Market. The urgent need for COVID-19 testing utilizing molecular diagnostic techniques propelled demand for diagnostic kits such as PCR and rapid antigen tests. Regulatory authorities expedited approval processes to address emergent healthcare challenges, facilitating market growth amidst the pandemic.

Competitive Analysis:

The Molecular Diagnostics Reagent industry is characterized by intense competition and consolidation among key players. However, technological innovations and product diversification enable medium and small businesses to enhance their market presence. Mergers and acquisitions are prevalent strategies among industry leaders, aimed at expanding product portfolios and market share.

Key Companies:

Leading players driving innovation and growth in the Molecular Diagnostics Reagent Market include:

  • Becton, Dickinson and Company
  • Bio-Rad Laboratories Inc
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Agilent Technologies, Inc.
  • Qiagen N.V.
  • Illumina, Inc.
  • DiaSorin S.p.A
  • Hologic Inc.
  • Other

Molecular Diagnostics Reagent Market Categorization

Molecular Diagnostics Reagent Market by Product

  • Sample Preparation Kits
  • PCR Assay Kits
  • In situ Hybridization Kits
  • Microarray Kit
  • Sequencing Kit

Molecular Diagnostics Reagent Market by Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa (MEA)

Table of Contents

1. Executive Summary

  • 1.1. Global Molecular Diagnostics Reagent Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value and Volume, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Production Output and Trade Statistics, 2018 - 2023

  • 3.1. Global Molecular Diagnostics Reagent Production Output, by Region, Value (US$ Bn) and Volume (Million Units), 2018 - 2023
    • 3.1.1. North America
    • 3.1.2. Europe
    • 3.1.3. Asia Pacific
    • 3.1.4. Latin America
    • 3.1.5. Middle East and Africa

4. Price Analysis, 2018 - 2023

  • 4.1. Global Average Price Analysis, by Product, US$ Per Unit, 2018 - 2023
  • 4.2. Prominent Factor Affecting Molecular Diagnostics Reagent Prices
  • 4.3. Global Average Price Analysis, by Region, US$ Per Unit

5. Global Molecular Diagnostics Reagent Market Outlook, 2018 - 2031

  • 5.1. Global Molecular Diagnostics Reagent Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Sample Preparation Kits
      • 5.1.1.2. PCR Assay Kits
      • 5.1.1.3. In situ Hybridization Kits
      • 5.1.1.4. Microarray Kit
      • 5.1.1.5. Sequencing Kit
  • 5.2. Global Molecular Diagnostics Reagent Market Outlook, by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Pathogen Detection
      • 5.2.1.2. Biomarker Screening
      • 5.2.1.3. Therapeutic Monitoring
      • 5.2.1.4. Others
  • 5.3. Global Molecular Diagnostics Reagent Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Hospitals
      • 5.3.1.2. Laboratories
      • 5.3.1.3. Research Institutes
      • 5.3.1.4. Biopharmaceutical Companies
      • 5.3.1.5. Others
  • 5.4. Global Molecular Diagnostics Reagent Market Outlook, by Region, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. North America
      • 5.4.1.2. Europe
      • 5.4.1.3. Asia Pacific
      • 5.4.1.4. Latin America
      • 5.4.1.5. Middle East & Africa

6. North America Molecular Diagnostics Reagent Market Outlook, 2018 - 2031

  • 6.1. North America Molecular Diagnostics Reagent Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Sample Preparation Kits
      • 6.1.1.2. PCR Assay Kits
      • 6.1.1.3. In situ Hybridization Kits
      • 6.1.1.4. Microarray Kit
      • 6.1.1.5. Sequencing Kit
  • 6.2. North America Molecular Diagnostics Reagent Market Outlook, by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Pathogen Detection
      • 6.2.1.2. Biomarker Screening
      • 6.2.1.3. Therapeutic Monitoring
      • 6.2.1.4. Others
  • 6.3. North America Molecular Diagnostics Reagent Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Hospitals
      • 6.3.1.2. Laboratories
      • 6.3.1.3. Research Institutes
      • 6.3.1.4. Biopharmaceutical Companies
      • 6.3.1.5. Others
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis
  • 6.4. North America Molecular Diagnostics Reagent Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. U.S. Molecular Diagnostics Reagent Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 6.4.1.2. U.S. Molecular Diagnostics Reagent Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 6.4.1.3. U.S. Molecular Diagnostics Reagent Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 6.4.1.4. Canada Molecular Diagnostics Reagent Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 6.4.1.5. Canada Molecular Diagnostics Reagent Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 6.4.1.6. Canada Molecular Diagnostics Reagent Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Europe Molecular Diagnostics Reagent Market Outlook, 2018 - 2031

  • 7.1. Europe Molecular Diagnostics Reagent Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Sample Preparation Kits
      • 7.1.1.2. PCR Assay Kits
      • 7.1.1.3. In situ Hybridization Kits
      • 7.1.1.4. Microarray Kit
      • 7.1.1.5. Sequencing Kit
  • 7.2. Europe Molecular Diagnostics Reagent Market Outlook, by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 7.2.1. Key Highlights
      • 7.2.1.1. Pathogen Detection
      • 7.2.1.2. Biomarker Screening
      • 7.2.1.3. Therapeutic Monitoring
      • 7.2.1.4. Others
  • 7.3. Europe Molecular Diagnostics Reagent Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Hospitals
      • 7.3.1.2. Laboratories
      • 7.3.1.3. Research Institutes
      • 7.3.1.4. Biopharmaceutical Companies
      • 7.3.1.5. Others
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis
  • 7.4. Europe Molecular Diagnostics Reagent Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. Germany Molecular Diagnostics Reagent Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.2. Germany Molecular Diagnostics Reagent Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.3. Germany Molecular Diagnostics Reagent Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.4. U.K. Molecular Diagnostics Reagent Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.5. U.K. Molecular Diagnostics Reagent Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.6. U.K. Molecular Diagnostics Reagent Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.7. France Molecular Diagnostics Reagent Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.8. France Molecular Diagnostics Reagent Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.9. France Molecular Diagnostics Reagent Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.10. Italy Molecular Diagnostics Reagent Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.11. Italy Molecular Diagnostics Reagent Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.12. Italy Molecular Diagnostics Reagent Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.13. Turkey Molecular Diagnostics Reagent Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.14. Turkey Molecular Diagnostics Reagent Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.15. Turkey Molecular Diagnostics Reagent Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.16. Russia Molecular Diagnostics Reagent Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.17. Russia Molecular Diagnostics Reagent Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.18. Russia Molecular Diagnostics Reagent Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.19. Rest of Europe Molecular Diagnostics Reagent Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.20. Rest of Europe Molecular Diagnostics Reagent Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 7.4.1.21. Rest of Europe Molecular Diagnostics Reagent Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Asia Pacific Molecular Diagnostics Reagent Market Outlook, 2018 - 2031

  • 8.1. Asia Pacific Molecular Diagnostics Reagent Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Sample Preparation Kits
      • 8.1.1.2. PCR Assay Kits
      • 8.1.1.3. In situ Hybridization Kits
      • 8.1.1.4. Microarray Kit
      • 8.1.1.5. Sequencing Kit
  • 8.2. Asia Pacific Molecular Diagnostics Reagent Market Outlook, by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Pathogen Detection
      • 8.2.1.2. Biomarker Screening
      • 8.2.1.3. Therapeutic Monitoring
      • 8.2.1.4. Others
  • 8.3. Asia Pacific Molecular Diagnostics Reagent Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Hospitals
      • 8.3.1.2. Laboratories
      • 8.3.1.3. Research Institutes
      • 8.3.1.4. Biopharmaceutical Companies
      • 8.3.1.5. Others
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis
  • 8.4. Asia Pacific Molecular Diagnostics Reagent Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. China Molecular Diagnostics Reagent Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.2. China Molecular Diagnostics Reagent Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.3. China Molecular Diagnostics Reagent Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.4. Japan Molecular Diagnostics Reagent Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.5. Japan Molecular Diagnostics Reagent Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.6. Japan Molecular Diagnostics Reagent Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.7. South Korea Molecular Diagnostics Reagent Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.8. South Korea Molecular Diagnostics Reagent Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.9. South Korea Molecular Diagnostics Reagent Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.10. India Molecular Diagnostics Reagent Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.11. India Molecular Diagnostics Reagent Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.12. India Molecular Diagnostics Reagent Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.13. Southeast Asia Molecular Diagnostics Reagent Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.14. Southeast Asia Molecular Diagnostics Reagent Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.15. Southeast Asia Molecular Diagnostics Reagent Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.16. Rest of Asia Pacific Molecular Diagnostics Reagent Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.17. Rest of Asia Pacific Molecular Diagnostics Reagent Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 8.4.1.18. Rest of Asia Pacific Molecular Diagnostics Reagent Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Latin America Molecular Diagnostics Reagent Market Outlook, 2018 - 2031

  • 9.1. Latin America Molecular Diagnostics Reagent Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 9.1.1. Key Highlights
      • 9.1.1.1. Sample Preparation Kits
      • 9.1.1.2. PCR Assay Kits
      • 9.1.1.3. In situ Hybridization Kits
      • 9.1.1.4. Microarray Kit
      • 9.1.1.5. Sequencing Kit
  • 9.2. Latin America Molecular Diagnostics Reagent Market Outlook, by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 9.2.1. Key Highlights
      • 9.2.1.1. Pathogen Detection
      • 9.2.1.2. Biomarker Screening
      • 9.2.1.3. Therapeutic Monitoring
      • 9.2.1.4. Others
  • 9.3. Latin America Molecular Diagnostics Reagent Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 9.3.1. Key Highlights
      • 9.3.1.1. Hospitals
      • 9.3.1.2. Laboratories
      • 9.3.1.3. Research Institutes
      • 9.3.1.4. Biopharmaceutical Companies
      • 9.3.1.5. Others
    • 9.3.2. BPS Analysis/Market Attractiveness Analysis
  • 9.4. Latin America Molecular Diagnostics Reagent Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 9.4.1. Key Highlights
      • 9.4.1.1. Brazil Molecular Diagnostics Reagent Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.4.1.2. Brazil Molecular Diagnostics Reagent Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.4.1.3. Brazil Molecular Diagnostics Reagent Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.4.1.4. Mexico Molecular Diagnostics Reagent Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.4.1.5. Mexico Molecular Diagnostics Reagent Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.4.1.6. Mexico Molecular Diagnostics Reagent Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.4.1.7. Argentina Molecular Diagnostics Reagent Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.4.1.8. Argentina Molecular Diagnostics Reagent Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.4.1.9. Argentina Molecular Diagnostics Reagent Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.4.1.10. Rest of Latin America Molecular Diagnostics Reagent Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.4.1.11. Rest of Latin America Molecular Diagnostics Reagent Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 9.4.1.12. Rest of Latin America Molecular Diagnostics Reagent Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 9.4.2. BPS Analysis/Market Attractiveness Analysis

10. Middle East & Africa Molecular Diagnostics Reagent Market Outlook, 2018 - 2031

  • 10.1. Middle East & Africa Molecular Diagnostics Reagent Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 10.1.1. Key Highlights
      • 10.1.1.1. Sample Preparation Kits
      • 10.1.1.2. PCR Assay Kits
      • 10.1.1.3. In situ Hybridization Kits
      • 10.1.1.4. Microarray Kit
      • 10.1.1.5. Sequencing Kit
  • 10.2. Middle East & Africa Molecular Diagnostics Reagent Market Outlook, by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 10.2.1. Key Highlights
      • 10.2.1.1. Pathogen Detection
      • 10.2.1.2. Biomarker Screening
      • 10.2.1.3. Therapeutic Monitoring
      • 10.2.1.4. Others
  • 10.3. Middle East & Africa Molecular Diagnostics Reagent Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 10.3.1. Key Highlights
      • 10.3.1.1. Hospitals
      • 10.3.1.2. Laboratories
      • 10.3.1.3. Research Institutes
      • 10.3.1.4. Biopharmaceutical Companies
      • 10.3.1.5. Others
    • 10.3.2. BPS Analysis/Market Attractiveness Analysis
  • 10.4. Middle East & Africa Molecular Diagnostics Reagent Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 10.4.1. Key Highlights
      • 10.4.1.1. GCC Molecular Diagnostics Reagent Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.2. GCC Molecular Diagnostics Reagent Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.3. GCC Molecular Diagnostics Reagent Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.4. South Africa Molecular Diagnostics Reagent Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.5. South Africa Molecular Diagnostics Reagent Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.6. South Africa Molecular Diagnostics Reagent Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.7. Egypt Molecular Diagnostics Reagent Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.8. Egypt Molecular Diagnostics Reagent Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.9. Egypt Molecular Diagnostics Reagent Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.10. Nigeria Molecular Diagnostics Reagent Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.11. Nigeria Molecular Diagnostics Reagent Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.12. Nigeria Molecular Diagnostics Reagent Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.13. Rest of Middle East & Africa Molecular Diagnostics Reagent Market by Product, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.14. Rest of Middle East & Africa Molecular Diagnostics Reagent Market by Application, Value (US$ Bn) and Volume (Units), 2018 - 2031
      • 10.4.1.15. Rest of Middle East & Africa Molecular Diagnostics Reagent Market by End User, Value (US$ Bn) and Volume (Units), 2018 - 2031
    • 10.4.2. BPS Analysis/Market Attractiveness Analysis

11. Competitive Landscape

  • 11.1. By Product Type vs by Application Heatmap
  • 11.2. Company Market Share Analysis, 2023
  • 11.3. Competitive Dashboard
  • 11.4. Company Profiles
    • 11.4.1. Becton, Dickinson and Company
      • 11.4.1.1. Company Overview
      • 11.4.1.2. Product Portfolio
      • 11.4.1.3. Financial Overview
      • 11.4.1.4. Business Strategies and Development
    • 11.4.2. Bio-Rad Laboratories Inc
      • 11.4.2.1. Company Overview
      • 11.4.2.2. Product Portfolio
      • 11.4.2.3. Financial Overview
      • 11.4.2.4. Business Strategies and Development
    • 11.4.3. Thermo Fisher Scientific Inc.
      • 11.4.3.1. Company Overview
      • 11.4.3.2. Product Portfolio
      • 11.4.3.3. Financial Overview
      • 11.4.3.4. Business Strategies and Development
    • 11.4.4. Merck KGaA
      • 11.4.4.1. Company Overview
      • 11.4.4.2. Product Portfolio
      • 11.4.4.3. Financial Overview
      • 11.4.4.4. Business Strategies and Development
    • 11.4.5. Agilent Technologies, Inc.
      • 11.4.5.1. Company Overview
      • 11.4.5.2. Product Portfolio
      • 11.4.5.3. Financial Overview
      • 11.4.5.4. Business Strategies and Development
    • 11.4.6. Qiagen N.V.
      • 11.4.6.1. Company Overview
      • 11.4.6.2. Product Portfolio
      • 11.4.6.3. Financial Overview
      • 11.4.6.4. Business Strategies and Development
    • 11.4.7. Illumina, Inc.
      • 11.4.7.1. Company Overview
      • 11.4.7.2. Product Portfolio
      • 11.4.7.3. Financial Overview
      • 11.4.7.4. Business Strategies and Development
    • 11.4.8. DiaSorin S.p.A
      • 11.4.8.1. Company Overview
      • 11.4.8.2. Product Portfolio
      • 11.4.8.3. Financial Overview
      • 11.4.8.4. Business Strategies and Development
    • 11.4.9. Hologic Inc.
      • 11.4.9.1. Company Overview
      • 11.4.9.2. Product Portfolio
      • 11.4.9.3. Financial Overview
      • 11.4.9.4. Business Strategies and Development

12. Appendix

  • 12.1. Research Methodology
  • 12.2. Report Assumptions
  • 12.3. Acronyms and Abbreviations
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!